These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20797911

  • 21. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
    Oh K, Park HB, Seo MW, Byoun OJ, Lee DS.
    Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
    [Abstract] [Full Text] [Related]

  • 22. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [Abstract] [Full Text] [Related]

  • 23. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 24. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
    Kumar V, Coulsell E, Ober B, Hubbard G, Sercarz E, Ward ES.
    J Immunol; 1997 Nov 15; 159(10):5150-6. PubMed ID: 9366445
    [Abstract] [Full Text] [Related]

  • 25. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Weinberg AD, Lemon M, Jones AJ, Vainiene M, Celnik B, Buenafe AC, Culbertson N, Bakke A, Vandenbark AA, Offner H.
    J Neurosci Res; 1996 Jan 01; 43(1):42-9. PubMed ID: 8838572
    [Abstract] [Full Text] [Related]

  • 26. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H.
    Lab Invest; 1997 Mar 01; 76(3):355-64. PubMed ID: 9121118
    [Abstract] [Full Text] [Related]

  • 27. Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE.
    Gültner S, Kuhlmann T, Hesse A, Weber JP, Riemer C, Baier M, Hutloff A.
    Eur J Immunol; 2010 Dec 01; 40(12):3403-12. PubMed ID: 21108463
    [Abstract] [Full Text] [Related]

  • 28. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portolés P.
    Int Immunol; 2008 Apr 01; 20(4):577-89. PubMed ID: 18310064
    [Abstract] [Full Text] [Related]

  • 29. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP, Piddlesden S, Morgan BP, Reynolds R.
    Exp Neurol; 1994 Oct 01; 129(2):299-310. PubMed ID: 7525334
    [Abstract] [Full Text] [Related]

  • 30. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes.
    Cao Y, Toben C, Na SY, Stark K, Nitschke L, Peterson A, Gold R, Schimpl A, Hünig T.
    Eur J Immunol; 2006 Jan 01; 36(1):207-15. PubMed ID: 16342234
    [Abstract] [Full Text] [Related]

  • 31. An organic CD4 inhibitor reduces the clinical and pathological symptoms of acute experimental allergic encephalomyelitis.
    Edling AE, Choksi S, Huang Z, Korngold R.
    J Autoimmun; 2002 Mar 01; 18(2):169-79. PubMed ID: 11908949
    [Abstract] [Full Text] [Related]

  • 32. The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis.
    Batoulis H, Uhl M, Addicks K, Lehmann PV, Kuerten S.
    Glia; 2012 May 01; 60(5):794-805. PubMed ID: 22319015
    [Abstract] [Full Text] [Related]

  • 33. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
    Mueller AM, Pedré X, Kleiter I, Hornberg M, Steinbrecher A, Giegerich G.
    J Neuroimmunol; 2005 Feb 01; 159(1-2):55-65. PubMed ID: 15652403
    [Abstract] [Full Text] [Related]

  • 34. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
    Bhopale MK, Hilliard B, Constantinescu CS, Fujioka T, Ventura E, Phillips SM, Rostami A.
    Exp Mol Pathol; 2014 Feb 01; 96(1):108-17. PubMed ID: 23872438
    [Abstract] [Full Text] [Related]

  • 35. Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis.
    Makar TK, Trisler D, Sura KT, Sultana S, Patel N, Bever CT.
    J Neurol Sci; 2008 Jul 15; 270(1-2):70-6. PubMed ID: 18374360
    [Abstract] [Full Text] [Related]

  • 36. Transplanting of mesenchymal stem cells may affect proliferation and function of CD4(+)T cells in experimental autoimmune encephalomyelitis.
    Zhu J, Zhang J, Li Q, Du Y, Qiao B, Hu X.
    Exp Clin Transplant; 2012 Oct 15; 10(5):492-500. PubMed ID: 22817386
    [Abstract] [Full Text] [Related]

  • 37. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Oct 15; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 38. Interleukin 7 is a potent co-stimulator of myelin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis.
    Bebo BF, Schuster JC, Adlard K, Vandenbark AA, Offner H.
    Cytokine; 2000 Apr 15; 12(4):324-31. PubMed ID: 10805212
    [Abstract] [Full Text] [Related]

  • 39. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
    Aharoni R, Eilam R, Stock A, Vainshtein A, Shezen E, Gal H, Friedman N, Arnon R.
    J Neuroimmunol; 2010 Aug 25; 225(1-2):100-11. PubMed ID: 20554028
    [Abstract] [Full Text] [Related]

  • 40. Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis.
    Tsutsui S, Hahn JN, Johnson TA, Ali Z, Jirik FR.
    Am J Pathol; 2008 Oct 25; 173(4):1029-41. PubMed ID: 18815152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.